Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

150
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
150
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Statistical Analysis: Overview01:11

Statistical Analysis: Overview

6.6K
When we take repeated measurements on the same or replicated samples, we will observe inconsistencies in the magnitude. These inconsistencies are called errors. To categorize and characterize these results and their errors, the researcher can use statistical analysis to determine the quality of the measurements and/or suitability of the methods.
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
6.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

134
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
134
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

371
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
371

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Personal and Family History of Cancer and Primary Lung Cancer Prevalence Among Never Smoking Disaggregated Asian American Women.

Cancers·2026
Same author

Cross-country comparison of perinatal outcomes between japanese mothers in the united states and japan: a cross-sectional study.

BMJ public health·2026
Same author

Trends in cardiovascular mortality among disaggregated Asian American subgroups: 2018-2022.

American journal of preventive cardiology·2026
Same author

Analysis of plasma extracellular vesicles in normal-weight and overweight type 2 diabetes mellitus using multimodal SERS and RNA-Seq.

Diabetes research and clinical practice·2026
Same author

MonotonicityTest: An R Package for Efficient Nonparametric Monotonicity Testing.

Observational studies·2026
Same author

Racial and geographic differences of opioid overdose deaths involving additional drugs of abuse: analysis of US mortality database.

British journal of anaesthesia·2026
Same journal

Hepatitis C Virus Cascade of Care in Florida Emergency Departments.

Medical care·2026
Same journal

Association of Neighborhood Socioeconomic Disadvantage and Uptake of Diabetes Prevention Interventions.

Medical care·2026
Same journal

Machine Learning for Evaluating the Heterogeneous Effects of Intensive In-Hospital Rehabilitation During the Postacute Phase After Hip Fracture Surgery on Activities of Daily Living.

Medical care·2026
Same journal

Hospital-Physician Integration and Differences in the Use of Orthopedic Care Across Race and Ethnicity.

Medical care·2026
Same journal

Temporal Misalignment and Selection Bias in "Burn Pit Smoke Exposure and Sleep Apnea in US Veterans.

Medical care·2026
Same journal

The Impact of an Oncology Hospital at Home Program on Health Care Costs.

Medical care·2026
查看所有相关文章

相关实验视频

Updated: Jul 8, 2025

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

10.7K

评估代用标记物的统计方法

Layla Parast1, Lu Tian2, Tianxi Cai3,4

  • 1Department of Statistics and Data Science, The University of Texas at Austin, Austin, TX.

Medical care
|December 11, 2023
PubMed
概括
此摘要是机器生成的。

评估代孕标记对于高效的临床试验至关重要. 这项研究表明,代孕解释了活检分数的18.2%和糖尿病发病率的59.6%的治疗效果,为未来的研究提供了工具.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

相关实验视频

Last Updated: Jul 8, 2025

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
08:16

Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates

Published on: May 9, 2016

10.7K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验方法论 临床试验方法论
  • 药物指标 (Pharmacometrics) 是一个指标.

背景情况:

  • 替代标记可以减少临床试验的持续时间,成本和患者负担.
  • 评估代用标记物的质量对于它们的可靠使用至关重要.
  • 需要方法来评估替代标记器如何捕捉治疗对主要结果的影响.

研究的目的:

  • 描述和说明评估代用标记物的方法.
  • 用治疗效果 (PTE) 的比例来评估代用标记物的质量. 解释.
  • 将这些方法应用于具有完全观察和时间到事件初级结果的环境中.

主要方法:

  • 利用了两个随机试验:一个是活检得分结果 (非酒精性脂肪肝疾病),另一个是时间到事件结果 (糖尿病发病率).
  • 采用统计方法来计算由代用标记解释的治疗效应的比例.
  • 使用提供R代码的Rsurrogate包的插图方法.

主要成果:

  • 对于活检得分结果,代用标记解释了治疗效果的18.2% (95% CI: 0.121, 0.240).
  • 对于发生糖尿病的时间结果,代用标记解释了治疗效果的59.6% (95% CI:0.404,0.760).
  • 这些结果量化了替代标记在不同的临床环境中的表现.

结论:

  • 该研究提供了评估代孕标记物的实用工具和方法.
  • 这些工具支持研究人员评估临床试验中代孕标记物的有效性.
  • 这些发现突出了不同结果类型中代孕标记的不同表现.